EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Ultrasonography‐guided core‐needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front‐line biopsies in a multicenter Italian study

Marco Picardi, Claudia Giordano iD, Elena Vigliar, Pio Zeppa, Imma Cozzolino, Novella Pugliese, Roberta Della Pepa, Maria Esposito, Davide Pio Abagnale, Mauro Ciriello, Giada Muccioli-Casadei, Giancarlo Troncone und 6 weitere

Hematological Oncology · 2023-12 · 41 (5) · 817-827

DOI: 10.1002/hon.3204 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Hematological Oncology, online erschienen am 06.07.2023. Verfasst von Marco Picardi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy. Hauptthemen laut MEDLINE: Lymphoma, Lymphadenopathy, Hodgkin Disease. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The reliability and safety of front‐line ultrasonography guided core needle biopsy (UG‐CNB) performed with specific uniform approach have never been evaluated in a large series of patients with lymphadenopathies suspected of lymphoma. The aim of this study was to assess the overall accuracy of UG‐CNB in the lymph node histological diagnosis, using a standard reference based on pathologist consensus, molecular biology, and/or surgery. We retrospectively checked the findings concerning the application of lymph node UG‐CNB from four Italian clinical units that routinely utilized 16‐gauge diameter modified Menghini needle under power‐Doppler ultrasonographic guidance. A data schedule was sent to all centers to investigate the information regarding techniques, results, and complications of lymph node UG‐CNB in untreated patients over a 12‐year period. Overall, 1000 (superficial target, n = 750; deep‐seated target, n = 250) biopsies have been evaluated in 1000 patients; other 48 biopsies (4.5%), screened in the same period, were excluded because inadequate for a confident histological diagnosis. Most patients were suffering from lymphomas (aggressive B‐cell non‐Hodgkin lymphoma [aBc‐NHL], 309 cases; indolent B‐cell [iBc]‐NHL, 279 cases; Hodgkin lymphoma [HL], 212 cases; and nodal peripheral T‐cell [NPTC]‐NHL, 30 cases) and 100 cases from metastatic carcinoma; 70 patients had non‐malignant disorders. The majority of CNB results met at least one criterion of the composite reference standard. The overall accuracy of the micro‐histological sampling was 97% (95% confidence interval: 95%–98%) for the series. The sensitivity of UG‐CNB for the detection of aBc‐NHL was 100%, for iBc‐NHL 95%, for HL 93%, and for NPTC‐NHL 90%, with an overall false negative rate of 3.3%. The complication rate was low (6% for all complications); no patient suffered from biopsy‐related complications of grade >2 according to the Common Terminology Criteria for Adverse Events. Lymph node UG‐CNB as mini‐invasive diagnostic procedure is effective with minimal risk for the patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphomaLymphadenopathyHodgkin DiseaseHumansRetrospective StudiesReproducibility of ResultsUltrasonographyBiopsy, NeedleItalyBiopsy, Large-Core Needle

Stichwörter der Autor:innen

core-needle biopsylymphoma diagnosisultrasonography

Autor:innen und Institutionen

  • Department of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
  • Department of Public Health, Federico II University Medical School, Naples, Italy.
  • Department of Medicine and Surgery, Salerno University Medical School, Baronissi, Italy.
  • Department of Mental and Physical Health and Preventive Medicine, University of Campania "L. Vanvitelli", Naples, Italy.
  • Department of Advanced Biomedical Sciences, Federico II University Medical School, Naples, Italy.
  • Department of General Surgery, Endocrinology, Orthopaedics, and Rehabilitations, Federico II University Medical School, Naples, Italy.

ORCID-Profile: Claudia Giordano

Zitieren

APA

Picardi, M., Giordano, C., Vigliar, E., Zeppa, P., Cozzolino, I., Pugliese, N., Della Pepa, R., Esposito, M., Abagnale, D. P., Ciriello, M., Muccioli-Casadei, G., Troncone, G., Russo, D., Mascolo, M., Varricchio, S., Accarino, R., Persico, M., & Pane, F. (2023). Ultrasonography‐guided core‐needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front‐line biopsies in a multicenter Italian study. Hematological Oncology, 41(5), 817-827. https://doi.org/10.1002/hon.3204

Vancouver

Picardi M, Giordano C, Vigliar E, Zeppa P, Cozzolino I, Pugliese N, et al. Ultrasonography‐guided core‐needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front‐line biopsies in a multicenter Italian study. Hematological Oncology. 2023;41(5):817-827. doi:10.1002/hon.3204

BibTeX
@article{Picardi2023,
  author = {Picardi, Marco and Giordano, Claudia and Vigliar, Elena and Zeppa, Pio and Cozzolino, Imma and Pugliese, Novella and Della Pepa, Roberta and Esposito, Maria and Abagnale, Davide Pio and Ciriello, Mauro and Muccioli-Casadei, Giada and Troncone, Giancarlo and Russo, Daniela and Mascolo, Massimo and Varricchio, Silvia and Accarino, Rossella and Persico, Marcello and Pane, Fabrizio},
  title = {Ultrasonography‐guided core‐needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front‐line biopsies in a multicenter Italian study},
  journal = {Hematological Oncology},
  year = {2023},
  volume = {41},
  number = {5},
  pages = {817--827},
  doi = {10.1002/hon.3204}
}
Kostenlos starten →